🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT)

RecruitingNAAges 18 Years - 99 YearsAllCharite University, Berlin, Germany
NCT06852443 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this prospective multicentred, stratified, parallel-group superiority study is to prevent and reduce the usage of Child Sexual Abuse Material (CSAM) by a Therapist Chat Service (TCS) and Selfhelp Platform for Self-Referred Patients, mostly men with a sexual interest in children. The interventions are based on Cognitive Behavioral Therapy (CBT) principles and designed to treat the sexual behavioral disorder related with CSAM consumption. 1. Participants in the Selfhelp modules group will show a statistically significantly higher proportion of reduction in CSAM behaviours four weeks after baseline, as compared to participants in the waitlist control group. 2. Participants in the Selfhelp modules followed by TCS group will show a statistically significantly higher reduction of CSAM behaviours compared to participants in the Selfhelp-only and TCS-only groups, post-intervention.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult participant (≥18 years); * recent (last 2 weeks) CSAM use or past CSAM use and self-reported risk; * proficiency in English, German or Spanish; * voluntary participation and agreement to the terms of the study. Exclusion Criteria: * Severe neuropsychiatric comorbidities (unstable psychotic disorder, organic brain damage, diminished intellectual functioning, untreated drug or alcohol addiction); * history of contact CSA perpetration (past or present); * ongoing criminal investigation, trial, punishment, or probation status for online or offline CSA or CSAM use; * current inpatient psychiatric treatment or other concurrent treatment targeting CSAM behaviours
💊

What it tests

  • Selfhelp modules
  • Therapist Chat Service
📍

Where

2 sites
Charité Universitätsmedizin Berlion
Berlin, Germany
Universitat Internacional de Catalunya (UIC), Catalonia, Spain
Barcelona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy